These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14743521)

  • 1. Schizophrenia, drug therapy, and monitoring.
    De Socio GV
    N Engl J Med; 2004 Jan; 350(4):415-6. PubMed ID: 14743521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].
    Peytavin G
    Med Mal Infect; 2004 Nov; 34 Spec No 2():20-1. PubMed ID: 15801535
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.
    Di Perri G; Aguilar Marucco D; Mondo A; Gonzalez de Requena D; Audagnotto S; Gobbi F; Bonora S
    Expert Opin Drug Saf; 2005 Sep; 4(5):821-36. PubMed ID: 16111446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.
    Cournos F; McKinnon K; Sullivan G
    J Clin Psychiatry; 2005; 66 Suppl 6():27-33. PubMed ID: 16107181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of serum levels of antiretroviral drugs].
    Kurowski M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review].
    van Oeffelt T; Prinsen EJ
    Tijdschr Psychiatr; 2016; 58(4):309-13. PubMed ID: 27075223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of antiretroviral agents in cirrhotic patients infected by HIV].
    Salmon-Céron D
    Med Mal Infect; 2004 Nov; 34 Spec No 2():14-9. PubMed ID: 15801534
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment: complications of antiretroviral therapy in children--a glass half full.
    Cervia JS
    AIDS Read; 2006 Oct; 16(10):551. PubMed ID: 17096473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Co-infection with HIV and viral hepatitis C].
    Pialoux G
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S218-23. PubMed ID: 17076000
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measuring plasma concentrations of antiretroviral drugs during HIV therapy].
    Langmann P
    Dtsch Med Wochenschr; 2008 May; 133(22):1205-6; author reply 1206-7. PubMed ID: 18491277
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.
    Soriano V; Vispo E; Labarga P; Barreiro P
    AIDS; 2008 Apr; 22(7):911-2. PubMed ID: 18427216
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of infants coinfected with HIV-1 and cytomegalovirus with combination antiretrovirals and ganciclovir.
    Saitoh A; Viani RM; Schrier RD; Spector SA
    J Allergy Clin Immunol; 2004 Oct; 114(4):983-5. PubMed ID: 15480350
    [No Abstract]   [Full Text] [Related]  

  • 20. A dramatic change in HIV treatment.
    Wilkins K; Maurer T; Berger T
    J Drugs Dermatol; 2004; 3(4):452-5. PubMed ID: 15303794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.